KKAy/TaСÊó,KKAy/Ta miceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½µÌÇÌÀ,Jiangtang DecoctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ñ×Ö¢Ãô¸ÐÐÔ,inflammation sensitivityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
V3Çø,V3 regionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÂÉö²¹Æ¢ÌÀ,warm-kidney and notify-spleen decoctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÂÇðÄÔÉñ¾ëÄ,hypothalamic neuropeptideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
cëÄÁªºÏÒȵºËØ,c peptides combined with insulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ת¼Òò×Ó7ÀàËÆÎï2,Transcription factor 7 like 2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ATP½áºÏºÐתÔ˵°°×A1,ATP-binding cassette transporter A1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Tangier²¡,Tangier diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȹܽáÔú,Ligation of the pancreatic ductÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô˶¯¼õ·Ê,losing weight with exerciseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹Ñ¹Ç¿¶ÈÖ¸Êý,Compressive Strength IndexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿àÜñÂóµ°°×ÌáÈ¡Îï,Tartarian buckwheat protein extractsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HCVÑÇÐÍ,HCV genotypeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹Ç´úл±ê¼ÇÎï,Biochemical bone markersÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼Ò×åÐÔ¸ßÈ©¹ÌͪѪ֢¢òÐÍ,Familial hyperaldosteronism type ¢òÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÄò²¡Ö«¶Ë»µ¾Ò,Acra gangrene caused by diabetesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ÷¿ØÐ§¹û,Regulating EffectsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×¿ºGraves²¡,Hyperthyroidism Graves diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°×ÄÚÕÏ,CataractÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¬ÉùÈ黯°×ÄÚÕÏÎü³ýÊõ,phacoemulsificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÇгýÊõ,NephrectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²£Á§ÌåÇиîÊõ,vitrectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÛ¿ô,orbitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ëÈé¸Ê¶¾ÛÌÇ¿¹Ô,galactomannan antigenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ñÁÐßÁàº,GlipizideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Æ÷¹Ù·¢Éú,organogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ñÁÐÃÀëå,glimepirideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
èã¹Ç,RadiusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û½Çµ°°×,cytokeratinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²£Á§ÌåÇгý,VitrectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚÖ¬ËØ,VisfatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Èð¸ñÁÐÄÎ,repaglinideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÅ´«ÂÊ,HeritabilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ¹¦ÄܼõÍË,HypothyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Çú¾úÇò,AspergillomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ת»¯ÊÔÑé,Transformation assayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
À×ÂåÎô·Ò,RaloxifeneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹²²¡,comorbidityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºó͹³ÉÐÎÊõ,kyphoplastyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÁ°àì¢ËáÄÆ,IbandronateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆøÎ¶,odorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¡²¡,myopathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÓÒ°¼ì²é·¨,perimetryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºó͹»ûÐÎ,KyphosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Ê±ûëÄ,galaninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºËØÒÀÀµÐÍ,insulin-dependentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÅÊÆ¿¹Ô,dominant antigenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÀÅÁ˾Ëû,EpalrestatÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ÉÈÜÐÔ°×ϸ°û½éËØ-2ÊÜÌå,sIL-2RÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾§×´Ì峬ÉùÈ黯,phacoemulsificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾ÉúÀíѧ,neurophysiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ìúµ÷ËØ,hepcidinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÀ¹ÇÖÊ,cementumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Æ¥·¥ËûÍ¡,pitavastatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ñÁÐàͪ,gliquidoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÀÂúÃ¹ËØ,minocyclineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶«Áâ¿Ë˨ø,BatroxobinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ïà¹Ø±êÖ¾Îï,related markersÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò©ÎïÒÅ´«Ñ§,pharmacogeneticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÅÉäÐÔµâ,RadioiodineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢С°©,MicrocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÀÎ÷ÂÉ,mexiletineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚÂð·ÈëÄ,endomorphinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»Çõ£ëåÀà,sulfonylureaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚ·ÖÃÚѧ,endocrinologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶þì¢ËáÑÎÀà,diphosphonatesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
˹·¥ËûÍ¡,simvastatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
À×ÅÁÃ¹ËØ°Ðµ°°×,mTORÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶à°ÐµãRNAiÔª¼þ,multiple RNAi elementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºÑ×,insulitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ëÈéÌÇÄý¼¯ËØ-3,galectin-3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°¢Â×ì¢ËáÄÆ,AlendronateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ä¤ºóÇ»,retroperitoneumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºËØ/ѪҺ,Insulin/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë«ì¢ËáÑÎ,bisphosphonateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ƤÖʼ¤ËØ,corticosteroidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éú³¤µ÷½ÚËØÀà,somatomedinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾§×´Ì峬ÉùÈ黯Îü³öÊõ,phacoemulsificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȸßÌÇËØ,GlucagonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ñôת,intravenous drug useÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÒÑù,cystoidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏËά״¼¡¶¯µ°°×,F-actinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±½äåÂí¡,benzbromaroneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊæÂåµØÌØ,sulodexideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë«´×ÈðÒò,diacereinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Åà¶àÆÕÀû,perindoprilÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ѪС°å·´Ó¦µ°°×-1,Thrombospondin-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ã׸ñÁд¼,miglitolÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âѳ²Õª³ý,ovariectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼××´ÏÙ¹¦ÄܼõµÍ,HypothyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È«¹ú°¬×̲¡×ۺϷÀÖÎʾ·¶Çø,China Comprehensive AIDS ResponseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÐÑõ½¡Éí²Ù,aerobic exerciseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
غͪ/ѪҺ,TESTOSTERONE/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ÙÐÔ¼××´ÅÔÏÙ¹¦ÄܼõÍËÖ¢,PseudohypoparathyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ý³éÑù,over-samplingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
LÑ¡ÔñËØ,L-selectinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹È°±õ£°·×ªÒÆÃ¸,transglutaminaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ðïÐÔ·¢×÷,seizureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|